Seaport Medspa Among Top 1% of Galderma Providers Nationwide

Seaport Medspa has earned national recognition as being in the top 1% of Galderma providers across the United States. This distinction reflects the exceptional volume of treatments we perform using Galderma’s most trusted products Dysport, Restylane, and Sculptra and speaks to both the trust our patients place in us and the expertise of our medical team.

Understanding Galderma’s Role in Aesthetics

Galderma is one of the leading global companies in medical aesthetics and dermatology. Its portfolio includes some of the most widely used injectables in the world: Dysport, a neuromodulator designed to soften dynamic lines; Restylane, a family of hyaluronic acid dermal fillers used for contouring and restoring volume; and Sculptra, a collagen stimulator that works to rebuild the skin’s underlying structure over time. These products are not only industry standards but also integral to the way providers customize safe and effective treatment plans for patients.

In 2023 alone, Galderma’s U.S. injector network trained more than 23,000 healthcare professionals, highlighting the scale of medical providers nationwide who rely on these products. At the same time, the U.S. aesthetic injectables market has grown to more than $4 billion annually, showing how rapidly patient demand for these treatments is increasing across the country.

What “Top 1%” Means

Being recognized in the top 1% of Galderma accounts is not just an abstract honor, it reflects measurable patient demand and consistent provider expertise. According to the American Med Spa Association, there are now more than 10,500 active medical spas in the U.S., not to mention thousands of dermatology and plastic surgery practices that also purchase Galderma injectables. To be ranked in the top 1% among such a broad and competitive field places Seaport Medspa within roughly the top 100 practices nationwide, at minimum.

This achievement is determined by Galderma based on purchase volume of its products, which is a direct measure of how many treatments a practice performs. In other words, the higher the purchase volume, the greater the number of patients receiving Dysport, Restylane, or Sculptra treatments. For our patients, this recognition translates into confidence that our team not only uses these products frequently, but also with the depth of experience that comes from performing a high volume of procedures safely and effectively.

Why It Matters for Patients

Recognition at this level is more than just a milestone for Seaport Medspa, it is a reassurance for our patients. High treatment volume, combined with advanced training and strict adherence to safety protocols, ensures consistency in outcomes and a deep familiarity with product behavior across different patient goals. Whether someone comes in for a subtle enhancement with Dysport, facial balancing with Restylane, or long-term collagen stimulation with Sculptra, they can feel confident knowing these treatments are being delivered by one of the most trusted and experienced Galderma accounts in the country.

Looking Ahead

Seaport Medspa’s recognition in the top 1% of Galderma accounts underscores a commitment to excellence, education, and patient-first care. As the aesthetics industry continues to grow, we remain dedicated to advancing our expertise, offering evidence-based treatments, and helping patients feel empowered and confident in their own skin.